CymaBay appoints Harish Shantharam as principal accounting officer; updates director comp

CymaBay Therapeutics, Inc.

Daniel Menold ceased as principal accounting officer on Jan 24, 2024, remains an employee.
Harish Shantharam (CFO) named principal accounting officer, in addition to his CFO role.
Non-Employee Director Compensation amended: annual equity award valued at ~$250k; initial award ~$400k.
Cash retainers unchanged: $40k annual base, $30k board chair, audit chair $20k, comp chair $15k, nominating chair $10k.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Daniel Menold

principal accounting officer

CymaBay Therapeutics, Inc.

Effective: 2024-01-24
Successor: Harish Shantharam
Filed: January 26, 2024, 6:59 PM ET

On January 24, 2024, Daniel Menold ceased to be the principal accounting officer of CymaBay and Harish Shantharam became the principal accounting officer in addition to his role as principal financial officer and Chief Financial Officer.

Appointed

Harish Shantharam

principal accounting officer

CymaBay Therapeutics, Inc.

Effective: 2024-01-24
Filed: January 26, 2024, 6:59 PM ET

On January 24, 2024, Daniel Menold ceased to be the principal accounting officer of CymaBay and Harish Shantharam became the principal accounting officer in addition to his role as principal financial officer and Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Daniel Menold departed as principal accounting officer at CymaBay Therapeutics, Inc..

Action: ceased
Role: principal accounting officer

Exact text from the filing

On January 24, 2024, Daniel Menold ceased to be the principal accounting officer of CymaBay and Harish Shantharam became the principal accounting officer in addition to his role as principal financial officer and Chief Financial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Harish Shantharam was appointed as principal accounting officer at CymaBay Therapeutics, Inc..

Action: became
Role: principal accounting officer

Exact text from the filing

On January 24, 2024, Daniel Menold ceased to be the principal accounting officer of CymaBay and Harish Shantharam became the principal accounting officer in addition to his role as principal financial officer and Chief Financial Officer.

View on SEC.gov

Source: SEC EDGAR

accession 0001193125-24-016706

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.